0000947871-23-001108.txt : 20231127
0000947871-23-001108.hdr.sgml : 20231127
20231127172908
ACCESSION NUMBER: 0000947871-23-001108
CONFORMED SUBMISSION TYPE: 144
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20231127
DATE AS OF CHANGE: 20231127
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: Apollomics Inc.
CENTRAL INDEX KEY: 0001944885
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 144
SEC ACT: 1933 Act
SEC FILE NUMBER: 001-41670
FILM NUMBER: 231441170
BUSINESS ADDRESS:
STREET 1: 989 EAST HILLSDALE BLVD.
STREET 2: STE 220
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
BUSINESS PHONE: 1-650-209-4055
MAIL ADDRESS:
STREET 1: 989 EAST HILLSDALE BLVD.
STREET 2: STE 220
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
REPORTING-OWNER:
COMPANY DATA:
COMPANY CONFORMED NAME: OrbiMed Advisors II Ltd
CENTRAL INDEX KEY: 0001968251
IRS NUMBER: 000000000
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 144
BUSINESS ADDRESS:
STREET 1: 190 ELGIN AVENUE
STREET 2: GEORGE TOWN
CITY: GRAND CAYMAN
STATE: E9
ZIP: KY1-9001
BUSINESS PHONE: 212-739-6400
MAIL ADDRESS:
STREET 1: 601 LEXINGTON AVENUE
STREET 2: 54TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
144
1
primary_doc.xml
144
0001968251
XXXXXXXX
LIVE
0001944885
Apollomics Inc.
001-41670
989 E. Hillsdale Blvd.
Suite 220
Foster City
CA
94404
650-209-4055
OrbiMed Asia Partners II, L.P.
Shareholder
Class A Ordinary Shares
Morgan Stanley
1585 Broadway
New York
NY
10036
9515756
11323750.00
89480790
11/27/2023
Nasdaq Stock Market
Class A ordinary shares
03/29/2023
Business combination
Issuer
N
9515756
03/29/2023
Cash
N
OrbiMed Asia GP II, L.P.
601 Lexington Ave.
54th Floor
New York
NY
10022
Class A ordinary shares
11/16/2023
6700000
8375000.00
OrbiMed Asia GP II, L.P. is the general partner of OrbiMed Asia Partners II, L.P., and OrbiMed Advisors II Limited is the genernal partner of OrbiMed Asia GP II, L.P. OrbiMed Advisors LLC is the advisory company of OrbiMed Asia Partners II, L.P.
11/27/2023
/s/ Douglas Coon, Chief Compliance Officer, OrbiMed Advisors II Limited, general partner of the general partner of OrbiMed Asia Partners II, L.P.